FRIDAY 9/16/16 BLOG: Footrace to Year-End: An Overview of

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks
FRIDAY 9/16/16 BLOG: Footrace to Year-End: An Overview of what is likely to be a RECORD year for HHSE / Medallion!

Greetings HHSE Friends & Followers. "The silence has been deafening," as reported to us by many shareholders. Why has the company refrained from P.R. Announcements, I.R. outreach, customary (scheduled) filings, as general communications?

The detailed answers would be voluminous. But the SHORT answer is: Establishment of Corporate Priorities (and a focus onto those areas of greatest immediate and long-term benefit to the Company).

In the past year, so many new opportunities have arisen, and so many market changes have occurred, that an evaluation of what is working best, and how to "do more of it" has become essential.

While handling the revisions and updates to the Company's Form 10 filing - and making the in-depth disclosures and managerial analyses required for a proper registration - one can take a high-altitude view of the business that the day-to-day distractions of managing a complex business can sometimes obfuscate. The patterns and data results that have emerged suggest that some of the Company's activities are less attractive than others - and by a significant degree.

For instance, two areas that are NOT meeting management's hopes are:

1). "Direct to DVD" Releases - the return-on-investment for low-end titles has fallen dramatically, as consumers are less willing to spend $9.96 on a no-name, non-theatrical horror video than in year's past. As the sales have declined, the cost-of-goods has stayed the same, as we have an obligation to keep the Walmart and Best Buy shelves well stocked (even for "slow" moving titles). This changing aspect of the market indicates that non-theatrical titles are less attractive now for HHSE / Medallion to release.

2). "Low-End" International Sales - After a highly visible presence this year at Cannes - including a booth, multiple full-page trade ads, and four official market screenings - we have concluded that the international market for "low-budget" / non-A-star features is insignificant. Most of the international licensors prefer to handle smaller films under "distribution deals" without paying an upfront licensing advance... and the only titles getting advances and big minimum guarantees are the higher-end, original productions. Accordingly, the benefit of handling and promoting smaller titles for the international market is dubious.

... and two areas that are EXCEEDING management's hopes are:

3). "Theatrical Services" - as major outlets (most notably NETFLIX and the PAY CABLE Networks) now REQUIRE some level of USA Theatrical release, the need for access to theatres has grown many-fold. Accordingly, the access that HHSE / Medallion have to secure screens at the top theatre chains nationwide has become a valuable commodity - and source of "theatrical servicing fees." This activity provides up-front payments to the Company - as opposed to prior business models in which the Company put up hundreds-of-thousands (or MILLIONS) of dollars in P&A Cash, Credit and Loans, only to have to wait YEARS for the revenue streams to pay it back (think back to the release of the movie "TWELVE" - and how painful that debt burden had been to the Company for the past five years). Additionally, we have found that MANY (if not MOST) of our paid, theatrical servicing clients have ALSO been engaging HHSE / Medallion to handle Home Video, Video on Demand and Television. So our access to theatres has become a strong acquisition tool as well as a source of operating cash flow... and the side benefit is that mass merchants and major video buyers (including REDBOX KIOSKS) have a strong preference towards carrying videos of films with theatrical momentum.

4). "Production Services" - As the worldwide film distribution market continued to mature in favor of bigger budgeted films, HHSE / Medallion have the challenge of trying to acquire rights to such titles. We have found that buying finished films on the festival circuit is a costly endeavor... with bidding wars against the Major Studios, the Weinsteins and Lionsgate often jacking prices to unprofitable levels. Instead, what we have found, is that facilitating the production of higher-end films is a smarter strategy for both controlling the distribution rights up-front... but also as a source of up-front "production services" fees for the Company. Mid-level productions such as "Shadow Vision", "True Freshman" and "The Final Minute" provide reasonable cash-flow for overhead and operations... while mega productions such as "Mother Goose" and "AJA" are structured even more lucratively for the Company. Having ownership of our own film gear and Grip Truck is another plus, as are the three State of Arkansas incentives for original productions (15% across the board; an additional 10% for Arkansas entities and residents; and additional 25% for technology positions and post-production under the EEDC).

So Parkinson, Shefte and Sims have been working to reorganize the DVD side to minimize costs and maximize efficiencies. As the Company has been very pleased with the consistent success that Cinedigm has achieved in placing two or three titles PER MONTH into Walmart and Best Buy (and sometimes into Target), we are looking for ways to increase profitability. Accordingly, over the next two months, HHSE new release DVD and BluRay fulfillment will be moved to Technicolor (Memphis) to save on freight, overhead and time efficiencies (and this is the warehouse facility where the Cinedigm distributed studios are shipped out from).

We are also looking at providing more managerial attention to both the Theatrical Servicing activities as well as to the Production Services.

We remain commited to our existing product lines, but want to provide greater attention and emphasis into those areas of greatest benefit. Below is a list of three titles already slated for Q4 theatrical release (there's another BIG title, a possible fourth Q4 theatrical release, but it's still in post-production at present and may not make it in time for Academy eligibility this year). Also below is a list of upcoming DVD and BluRay placements for Walmart (and other Mass Merchants), showing an ongoing commitment to the physical home video side of the business. Each of these titles is also being exploited day-and-date with home video onto Video-On-Demand Platforms, and 60-days later, the theatrical items will be available for subscription streaming through Netflix.

These managerial priorities impact the daily operations and affect the narrative of the Form 10 and business plan. But they are the reasons that the Company has been incredibly QUIET for several months. This is about to change, beginning Monday with a nice feature interview from Uptick Newswire and I-Heart Radio / as well as Investor's Hangout featured visibility. There will also be traditional Newswire press releases, and enhanced visibility from social media platforms and websites. The Q2 filings at long last will be released in the next few days, and as the Company feels prepared to provide information on the current status of the FORM 10 and the pre-build-up of features for VODWIZ, these will also be released (but not necessarily next week).

We are appreciative of the extreme patience that our LONGS have provided to the Company - and know that you have suffered for months under a cone of silence from the Company. We recognized that the Stock Price and Volume have suffered, and we hope that our ignition of outreach through information and disclosures will help reverse this currently low pricing status.

HAVE A GREAT WEEKEND > for you College Football Fans, the Oklahoma vs Ohio State game (7pm Eastern Time, Fox Sports) tomorrow could be Epic!

Q4 THEATRICALS

“SPICES OF LIBERTY” – Oct. 28 / Top 25 Markets / “Bollywood” specialty locations

https://www.youtube.com/watch?v=nR8iN23mfHU

“CHOSEN” – Dec. 2 – NY, LA, plus other top 10 DMA’s / Indie-Art film locations

https://www.youtube.com/watch?v=9P-ypYAjWDk

“STANLEY: A MAN OF VARIETY” – Dec. 16 / Top 25 Markets / Indie-Art film locations

http://www.imdb.com/video/user/vi3345331993

The June test release of “THE HOMELESS BILLIONAIRE” was a financial success. However, the film’s director has since commenced on some re-editing / remixing issues that he felt could be improved. Accordingly, the theatrical expansion dates for that release are not yet set. The Company also is continuing to book playdates for “A REMARKABLE LIFE.” Another title pegged for Academy Qualifying release, may not be completed by Dec. 16, and is not appearing yet on our schedules; but still may be added.

Q4 & Q1 DVD & BLU RAYS / MASS MERCHANTS (Shipping in Q4)

OCTOBER

BAD GIRL – Urban / Christian / Family

THE CONGREGATION – Urban / Christian / Family

DAY OF REDEMPTION – Action / Thriller

NOVEMBER

JOB’S DAUGHTER – Action / Thriller

REVELATIONS – Thriller / Christian

DINOSAURS OF THE JURASSIC (Walmart Canada) – Edu Documentary

JANUARY

PALI ROAD – Sci-Fi Thriller

LOST IN THE PACIFIC – Sci-Fi Thriller

DINOSAURS OF THE JURASSIC (Walmart USA) – Edu Documentary

FEBRUARY

BONOBOS: BACK TO THE WILD (Walmart USA)* - Nature Docu-Drama

SLEEPER CELL: THE ALGERIAN (Walmart USA)* - Action / Thriller / Politica
COME OUT FIGHTING - Action / Adventure
GUEST HOUSE - Horror-Thriller


* Both were previously PLANNED for release to mass merchants earlier via ALCHEMY, but were held back for release later, once HHSE recognized the financial duress of Alchemy


Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skyven's Heat Pump Sets New Steam Efficiency Benchmark

Updated Category News Views 3

The Efficiency Game-Changer in Industrial Steam Swinging in like a seasoned market shake-up is Skyven Technologies, raising eyebrows—and interest—by nailing a coefficient of performance (COP) of 8.0 for their Arcturus heat pump. You don't have to be a market wizard to know that's a big leap from the initial COP of 6.5. It's more than just numbers on a page; this...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Geek+ Spurs Growth with 35.5% Order Surge and New Model

Updated Category News Views 2

Unexpected Surge in Orders Drives Geek+ It looks like Geek+ isn't just playing around in the robotics sandbox anymore. They're delivering some serious results, reporting a 35.5% increase in new signed orders reaching a whopping RMB2.385 billion for the first half of 2026. That's not chump change, and it injects a healthy dose of optimism into their future performance...

Continue Reading
Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Updated Category News Views 0

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 2

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
California's Annual Recovery Happens Event Unites Community

Updated Category News Views 2

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

Continue Reading
Wahl's Bold Move: The Baldscaper™ Revolution

Updated Category News Views 2

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Continue Reading
Common Threads Takes Nutrition Education Digital in 2026

Updated Category News Views 4

Digitizing 23 Years of Nutrition Know-How Common Threads has been in the trenches for over two decades, teaching kids and families how to eat right and cook healthier meals. Now, the nonprofit's dragging its vast experience into the digital realm, rolling out a beefed-up version of its TEACH platform this September 15th. Through new certificate courses in Nutrition...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 1

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Sector Gains Momentum as Market Reacts to Rate Cuts

Updated Category News Views 63

Market Overview: Modest Gains and Trader Optimism As the week kicks off, U.S. index futures are showing slight upticks, signaling that traders remain hopeful despite waning enthusiasm from the recent rate cuts. There's a growing expectation that the technology sector will support the market, especially with recent developments involving Intel Corp (NASDAQ: INTC)....

Continue Reading
BDA Strengthens Portfolio with Acquisition of Harper + Scott

Updated Category News Views 944

BDA Strengthens Portfolio with Acquisition of Harper + Scott Deal Grows BDA's Roster of Enterprise Customers, Unites Top Branded Merchandise Agencies Bensussen Deutsch & Associates, LLC (BDA), the nation's leading Merchandise Agency™ for iconic brands including Major League Baseball, Johnson & Johnson, and The Home Depot, has acquired Harper + Scott, a creative branded...

Continue Reading
Mexco Energy Corporation Achieves Growth Amid Oil Price Challenges

Updated Category News Views 170

Mexco Energy Corporation Reports Impressive Financial Performance Mexco Energy Corporation (NYSE American: MXC), based in Midland, Texas, has reported notable financial results for the recently concluded six-month period. The company has achieved a net income of $565,457, translating to $0.27 per diluted share for the interim period ending September 30. Operating Revenues...

Continue Reading
Exciting Developments in (Z)-Endoxifen Research at SABCS 2025

Updated Category News Views 167

Atossa Therapeutics' Bold Moves in Breast Cancer Treatment Atossa Therapeutics, Inc. (NASDAQ: ATOS) is making waves in the oncology sector, focusing on innovative therapies for breast cancer. The company has recently announced that four abstracts on (Z)-endoxifen have been accepted for presentation at the renowned San Antonio Breast Cancer Symposium (SABCS), scheduled for...

Continue Reading
JPMorgan Global Growth & Income Adds New Ordinary Shares

Updated Category News Views 202

JPMorgan Global Growth & Income Expands Share Capital Recently, JPMorgan Global Growth & Income Plc took an important step by issuing 100,000 new Ordinary Shares priced at 581.70 pence each. This decision to issue additional shares aligns with the company’s ongoing strategy to enhance its operational capacity and foster growth. Impact on Share Capital This issuance has...

Continue Reading